Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
87.42 USD | -1.79% |
|
-1.02% | +6.79% |
Feb. 07 | Vaxcyte Insider Sold Shares Worth $450,369, According to a Recent SEC Filing | MT |
Feb. 05 | Vaxcyte Advances Phase 2 Study on Infant Pneumococcal Disease Prevention to Final Stage | MT |
End-of-day quotes
Compared values
Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
---|---|---|---|---|---|---|---|---|---|---|---|
VAXCYTE, INC. | Bio Therapeutic Drugs | -1.79% | -1.02% | +6.79% | +17.91% | - | 10.9B | Neutral | Neutral | Neutral |
Technical Rankings Surperformance
- Stock Market
- Equities
- PCVX Stock
- Charts Vaxcyte, Inc.
- Comparison Chart